Process Analytical Technology (PAT)

Recorded Webinar | Michael Levin | From: Nov 23, 2021 - To: Dec 31, 2021

Training Options & Pricing

Error Conference Exists In Wish-list.

Congrats Conference Added In Wish-list.

Recording
   $229  
DVD
   $239  
Recording + DVD
   $399  
Transcript (Pdf)
   $229  
Recording & Transcript (Pdf)
   $389  
DVD & Transcript (Pdf)
   $399  


Order Form

Process Analytical Technology (PAT): The Impact on Pharmaceuticals Manufacturing and Validation Needs/Requirements

This webinar will provide an insight into the practical aspects of Process Analytical Technology (PAT) and will be an invaluable source of information on various technologies and approaches that fit the PAT definitions. You will learn about regulatory initiatives to improve the quality of pharmaceutical manufacturing using PAT and validation thereof. No special technical background is required.

Areas Covered:-

This webinar course covers the following topics on Process Analytical Technology:

  • What is FDA PAT Initiative and how to comply with innovation requirement
  • FDA PAT Guidance Q&A with examples
  • Multivariate data acquisition and analysis tools
  • Modern process analyzers
  • Process and endpoint monitoring and control tools
  • Current GMP practices, QbD, and Risk-based PAT framework
  • Life Cycle Validation approach applied to analytical technology

Who Should Attend:-

This webinar is intended for formulators, process engineers, validation specialists, and quality assurance personnel, as well as production managers occupied with process and product quality assurance. It will also provide a good source of information for anyone involved in risk mitigation and regulatory compliance.

Michael Levin

Michael Levin, Ph.D., has edited a very popular “Pharmaceutical Process Scale-Up” handbook (3rd edition published in 2011) and has contributed chapters on “Tablet Press Instrumentation” and “Wet Granulation: End-Point Determination and Scale-Up” in the Encyclopedia of Pharmaceutical Technology. For more than 30 years he has managed an instrumentation company providing monitoring and real-time process data on pharmaceutical solid dosage equipment.